Human fetal dermal fibroblast-myeloid cell diversity is characterized by dominance of pro-healing Annexin1-FPR1 signaling.
Human fetal dermal fibroblast-myeloid cell diversity is characterized by dominance of pro-healing Annexin1-FPR1 signaling.
复制标题
DOI:
10.1016/j.isci.2023.107533
复制
发表时间:
2023-09-15
期刊:
影响因子:
5.8
通讯作者:
Sen, Chandan K.
中科院分区:
文献类型:
--
作者:
Srivastava, Rajneesh;Singh, Kanhaiya;Abouhashem, Ahmed S.;Kumar, Manishekhar;Kacar, Sedat;Verma, Sumit S.;Mohanty, Sujit K.;Sinha, Mithun;Ghatak, Subhadip;Xuan, Yi;Sen, Chandan K.
Fetal skin achieves scarless wound repair. Dermal fibroblasts play a central role in extracellular matrix deposition and scarring outcomes. Both fetal and gingival wound repair share minimal scarring outcomes. We tested the hypothesis that compared to adult skin fibroblasts, human fetal skin fibroblast diversity is unique and partly overlaps with gingival skin fibroblasts. Human fetal skin (FS, n = 3), gingiva (HGG, n = 13), and mature skin (MS, n = 13) were compared at single-cell resolution. Dermal fibroblasts, the most abundant cluster, were examined to establish a connectome with other skin cells. Annexin1-FPR1 signaling pathway was dominant in both FS as well as HGG fibroblasts and related myeloid cells while scanty in MS fibroblasts. Myeloid-specific FPR1-ORF delivered in murine wound edge using tissue nanotransfection (TNT) technology significantly enhanced the quality of healing. Pseudotime analyses identified the co-existence of an HGG fibroblast subset with FPR1high myeloid cells of fetal origin indicating common underlying biological processes. Fibroblast subpopulation, unique to human fetal skin, and gingiva minimize scar Fetal fibroblasts and myeloid cells share energy metabolism gene sets Annexin1-FPR1 signaling promotes tissue repair and regeneration in fetal skin Myeloid-specific FPR1 delivery via TNT enhances quality of wound healing Molecular biology; Immunology; Cell biology; Transcriptomics
登录
查看更多内容
影响因子:
64.8
作者:
Cao, Junyue;Spielmann, Malte;Shendure, Jay
通讯作者:
Shendure, Jay
DOI:
10.3390/ph14050456
发表时间:
2021-05-12
期刊:
Pharmaceuticals (Basel, Switzerland)
影响因子:
--
作者:
Cho YD;Kim KH;Lee YM;Ku Y;Seol YJ
通讯作者:
Seol YJ
影响因子:
17.1
作者:
Eming SA;Martin P;Tomic-Canic M
通讯作者:
Tomic-Canic M
影响因子:
--
作者:
Jürgensen HJ;Silva LM;Krigslund O;van Putten S;Madsen DH;Behrendt N;Engelholm LH;Bugge TH
通讯作者:
Bugge TH
影响因子:
2.6
作者:
Bullard, KM;Longaker, MT;Lorenz, HP
通讯作者:
Lorenz, HP